These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36645381)

  • 1. Effective carrier-free gene-silencing activity of sphingosine-modified siRNAs.
    Fernandez C; Giorgees I; Goss E; Desaulniers JP
    Org Biomol Chem; 2023 Mar; 21(10):2107-2117. PubMed ID: 36645381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sixteen Different Types of Lipid-Conjugated siRNAs Containing Saturated and Unsaturated Fatty Acids and Exhibiting Enhanced RNAi Potency.
    Kubo T; Nishimura Y; Sato Y; Yanagihara K; Seyama T
    ACS Chem Biol; 2021 Jan; 16(1):150-164. PubMed ID: 33346648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Conjugation of Gallium-(III)-Corroles to Short Interfering RNA(siRNA) Providing Real-Time siRNA Imaging and Gene Silencing.
    Giorgees I; Affe V; Williams I; Desaulniers JP
    Chempluschem; 2024 Jun; 89(6):e202400084. PubMed ID: 38457624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo.
    Biscans A; Coles A; Echeverria D; Khvorova A
    J Control Release; 2019 May; 302():116-125. PubMed ID: 30940496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA: Mechanism of action, challenges, and therapeutic approaches.
    Alshaer W; Zureigat H; Al Karaki A; Al-Kadash A; Gharaibeh L; Hatmal MM; Aljabali AAA; Awidi A
    Eur J Pharmacol; 2021 Aug; 905():174178. PubMed ID: 34044011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted gene silencing by small interfering RNA-based knock-down technology.
    Zhang J; Hua ZC
    Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing mediated by small interfering RNAs in mammalian cells.
    Scherr M; Morgan MA; Eder M
    Curr Med Chem; 2003 Feb; 10(3):245-56. PubMed ID: 12570711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Biological Evaluation of a Novel Integrin α
    Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAs.
    Dong X; Zheng W
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
    Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
    Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
    Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity.
    Hammill ML; Tsubaki K; Salim L; Varley AJ; Giorgees I; Kitamura M; Okauchi T; Desaulniers JP
    ACS Med Chem Lett; 2022 Apr; 13(4):695-700. PubMed ID: 35450364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system.
    Beale G; Hollins AJ; Benboubetra M; Sohail M; Fox SP; Benter I; Akhtar S
    J Drug Target; 2003 Aug; 11(7):449-56. PubMed ID: 15203934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugating phosphospermines to siRNAs for improved stability in serum, intracellular delivery and RNAi-mediated gene silencing.
    Paris C; Moreau V; Deglane G; Karim L; Couturier B; Bonnet ME; Kedinger V; Messmer M; Bolcato-Bellemin AL; Behr JP; Erbacher P; Lenne-Samuel N
    Mol Pharm; 2012 Dec; 9(12):3464-75. PubMed ID: 23148419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular Vesicles.
    Biscans A; Haraszti RA; Echeverria D; Miller R; Didiot MC; Nikan M; Roux L; Aronin N; Khvorova A
    Mol Ther; 2018 Jun; 26(6):1520-1528. PubMed ID: 29699940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
    Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
    Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.